logo ABL
  • Home
  • Clinical solutions
  • Clinical applications
    • MyNadis/MyNadis Pro
    See all applications
  • News
  • Company
    • At a glance
    • Careers
    See all applications
  • Distributors
  • Contact
  • Home
  • Clinical solutions
  • Clinical applications
    • MyNadis/MyNadis Pro
    See all applications
  • News
  • Company
    • At a glance
    • Careers
    See all applications
  • Distributors
  • Contact
Read more

EMRs - Registries - Integration tool

Read more
Read more
Read more

Clinical solutions

Discover our solutions

Clinical applications

Discover our applications

  • UltraGene Combo2Screen SARS-CoV-2 Assay Now Registered at the INVIMA in Colombia

    Jan 11, 2021

    We are pleased to announce today that the RT-PCR test for COVID-19 detection UltraGene® Combo2Screen SARS-CoV-2 assay is now officially registered at the INVIMA in Colombia. To learn more about UltraGene® Combo2Screen SARS-CoV-2 assay, please visit https://www.ablsa.com/laboratory-applications/ultra…

    Read more
  • UltraGene Combo2Screen SARS-CoV-2 Assay Now Registered at the ALMBiH in Bosnia

    Jan 11, 2021

    We are pleased to announce today that the RT-PCR test for COVID-19 detection UltraGene® Combo2Screen SARS-CoV-2 assay is now officially registered at the ALMBiH in Bosnia. To learn more about UltraGene® Combo2Screen SARS-CoV-2 assay, please visit https://www.ablsa.com/laboratory-applications/ultrage…

    Read more
  • Highly Satisfactory Accuracy for the UltraGene Combo2Screen SARS-CoV-2 Assay on the QCMD 2020 SARS-CoV-2 EQA Programme

    Dec 18, 2020

    We are pleased to announce that the UltraGene Combo2Screen SARS-CoV-2 Assay has obtained Highly Satisfactory results (with a 100% accuracy for qualitative detection of all QCMD blinded samples, including with lowest viral load) in the context of the QCMD 2020 SARS-CoV-2 EQA Programme (SCV2_20…

    Read more
  • New Publication on DeepChek®-HCV Drug Resistance Assays and Software (Virology Journal)

    Jul 17, 2020

    Detection of low-level HCV variants in DAA treated patients: comparison amongst three different NGS data analysis protocols Caputo et al. Virology Journal (2020) 17:103 https://doi.org/10.1186/s12985-020-01381-3 Abstract Background: Notwithstanding the efforts of direct-acting antivirals (DAAs) for…

    Read more
  • ABL Appointed as the Exclusive Distributor of all NimaGen sequencing products for France, Belgium and Luxembourg

    Jul 15, 2020

    We are pleased to announce that Nimagen appointed ABL as its exclusive distribution partner for Sequencing Products in France, Belgium and Luxembourg. The partnership was formalized on March 17th 2020 and will help all labs involved in sequencing to get access to robust and cost-effective solutions…

    Read more
  • Advanced Biological Laboratories (ABL) Releases the First & Unique Commercial CE-IVD Registered COVID-19 rRT-PCR Assay Validated also for Human Saliva Specimens

    Jul 06, 2020

    Single well rRT-PCR assay, including highly sensitive detection of 2 targets and housekeeping internal control, with full automation   Luxembourg (Luxembourg), Metz (France), — July 06 — Advanced Biological Laboratories (ABL) announced today the CE-IVD marking of its UltraGene® Combo2Screen SARS-CoV…

    Read more
  • SARS-CoV-2 PCR Assay Now Approved for Human Saliva Specimens

    Jun 17, 2020

    First rt-PCR detection kit CE marked for nasopharyngeal and saliva samples. Improve COVID-19 management with non-invasive, open and sensitive assay.  Luxembourg (Luxembourg), Metz (France), — June 17 — Advanced Biological Laboratories (ABL) announced today the validation of its CE-IVD UltraGene® Com…

    Read more
  • Highly Satisfactory Accuracy for the UltraGene Combo2Screen SARS-CoV-2 Assay on the QCMD 2020 Coronavirus Outbreak Preparedness EQA Pilot Study

    May 29, 2020

    We are pleased to announce that the UltraGene Combo2Screen SARS-CoV-2 Assay has obtained Highly Satisfactory results (with a 100% accuracy for qualitative detection of all QCMD blinded samples, including with lowest viral load) in the context of the QCMD 2020 Coronavirus Outbreak Preparedness EQA Pi…

    Read more
  • Advanced Biological Laboratories Receives CE-IVD Registration for its UltraGene Combo2Screen SARS-CoV-2 Assay

    May 21, 2020

    Optimizing COVID-19 management through highly sensitive SARS-CoV-2 detection test. Luxembourg (Luxembourg), Metz (France) — May 21— Advanced Biological Laboratories (ABL) announced today the CE-IVD registration of its UltraGene® Combo2Screen SARS-CoV-2 assay, now available for in-vitro diagnostics u…

    Read more
Read more news

Newsletter

If you want to be informed about our latest products and events, please subscribe to our newsletter. You will get the latest news straight to your e-mail box.

Sitemap

  • Homepage
  • Laboratory
  • Laboratory solutions
  • Laboratory applications
  • Clinical
  • News
  • Company
  • Distributors
  • Contact

ABL SA Group

17 rue des Jardiniers
L-1835 Luxembourg
Luxembourg

T: (+352) 26 38 96 761

F: (+352) 26 38 96 76 31

contact@ablsa.com

Disclaimer IFU